Metraipolis › archive › dc_21517a76ecf5

Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia — Europe PMC PMID:41601621

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41601621
DOI
10.3389/fimmu.2025.1709417
License (as archived)
solo-consultazione
Archived
2026-11-06T21:11:37.031Z
SHA-256 of the archived text
1e6b77201a4a5eda6902ef6acd68609ccf751e1738d99ac915cffac3decd269c
Stable URL of this page
https://metraipolis.com/documento/dc_21517a76ecf5

How to cite

Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia — Europe PMC PMID:41601621 — Europe PMC (en), https://europepmc.org/article/MED/41601621 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21517a76ecf5 (Metraipolis archive dc_21517a76ecf5, sha256 1e6b77201a4a5eda6902ef6acd68609ccf751e1738d99ac915cffac3decd269c)
BibTeX
@misc{dc21517a76ecf5,
  title = {Identification and validation of HOXB3 hypomethylation as a novel prognostically epigenetic biomarker in acute myeloid leukemia — Europe PMC PMID:41601621},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601621},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21517a76ecf5; sha256 1e6b77201a4a5eda6902ef6acd68609ccf751e1738d99ac915cffac3decd269c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601621. Agents can read the archived copy with the MCP tool read_document.